Prokidney (PROK) Research & Development (2021 - 2026)

Prokidney (PROK) has 6 years of Research & Development data on file, last reported at $33.8 million in Q1 2026.

• Research & Development for Q1 2026 came in at $33.8 million, up 24.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $120.7 million (down 5.48% YoY), and the FY2025 annual result was $114.1 million, down 10.61% from the prior year.
• Research & Development declined to $33.8 million in Q1 2026 per PROK's latest filing, from $34.2 million in the prior quarter.
• Over five years, Research & Development peaked at $39.8 million in Q4 2024 and troughed at $11.6 million in Q2 2022.
• A 5-year average of $27.3 million and a median of $27.2 million in 2024 frame the typical range for Research & Development.
• The sharpest annual moves came in 2023 and 2025: Research & Development soared 128.1% in 2023, then slipped 14.17% in 2025.
• A 5-year view of Research & Development shows it stood at $20.9 million in 2022, then rose by 7.84% to $22.5 million in 2023, then surged by 76.58% to $39.8 million in 2024, then dropped by 14.14% to $34.2 million in 2025, then retreated by 0.92% to $33.8 million in 2026.
• Business Quant data shows PROK's Research & Development at $33.8 million in Q1 2026, $34.2 million in Q4 2025, and $26.8 million in Q3 2025.